|
Market Closed -
OTC Markets
18:26:06 02/06/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.8200 USD | +2.50% |
|
+95.47% | +64.00% |
| 05-14 | Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 | CI |
| 04-07 | Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
Company Valuation: Cell Source, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 29.13 | 63.92 | 43.22 | 29.96 | 17.95 | 15.26 |
| Change | - | 119.45% | -32.39% | -30.67% | -40.09% | -14.98% |
| Enterprise Value (EV) 1 | 31.8 | 68.58 | 49.62 | 37.65 | 27.22 | 25.77 |
| Change | - | 115.68% | -27.64% | -24.14% | -27.68% | -5.35% |
| P/E | -5.97x | -10.7x | -6.58x | -4.68x | -2.65x | -2.49x |
| PBR | -5.19x | -8.19x | -4.48x | -2.43x | -1.17x | -0.85x |
| PEG | - | -7.3x | -1.59x | 0.7x | 0.58x | 0.1x |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | -8.36x | -18.9x | -12.3x | -9.02x | -6.51x | -6.71x |
| EV / FCF | -39.4x | -44.2x | -22.8x | -28.2x | -26.2x | -37.4x |
| FCF Yield | -2.54% | -2.26% | -4.38% | -3.55% | -3.82% | -2.68% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.1842 | -0.1869 | -0.1946 | -0.1816 | -0.1733 | -0.1406 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | -3.805 | -3.638 | -4.019 | -4.175 | -4.183 | -3.84 |
| Net income 1 | -4.475 | -4.56 | -5.472 | -5.168 | -5.321 | -4.513 |
| Net Debt 1 | 2.67 | 4.661 | 6.404 | 7.682 | 9.274 | 10.51 |
| Reference price 2 | 1.1000 | 2.0000 | 1.2805 | 0.8500 | 0.4600 | 0.3500 |
| Nbr of stocks (in thousands) | 26,479 | 31,960 | 33,752 | 35,252 | 39,022 | 43,602 |
| Announcement Date | 30/03/20 | 15/04/21 | 15/04/22 | 08/08/23 | 24/06/24 | 07/04/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 27.54M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.98x | 31.37x | 12.47x | 0.31% | 39.06B | |
| Weighted average by Cap. | 22.27x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CLCS Stock
- Valuation Cell Source, Inc.
Select your edition
All financial news and data tailored to specific country editions
